France's Abionyx to buy IRIS Pharma Holding

Abionyx Pharma SA

17/11/2021 18:08

Nov 17 (Reuters) - French biopharmaceutical company Abionyx
 ABNX.PA  said on Wednesday it had signed a deal to buy the
owner of ophthalmological group IRIS Pharma.
    Abionyx said it would finance the deal, which values IRIS
Pharma Holding at 5 million euros ($5.66 million), through a
capital increase pricing its shares at 3.60 euros each.

($1 = 0.8832 euros)

 (Reporting by Sarah Morland
Editing by Chris Reese)
 ((sarah.morland@thomsonreuters.com; +48 58 769 65 92;))